Gene Drives Will Eliminate Malaria Before Vaccines Do — If We Can Solve the Resistance Problem
Gene drives using CRISPR-Cas9 can spread anti-malarial modifications through Anopheles mosquito populations at super-Mendelian frequencies. Target Malaria has shown this works in caged populations: driving female sterility alleles to fixation within 7-11 generations (Hammond et al., 2016, Nature Biotechnology; Kyrou et al., 2018, Nature Biotechnology).
But resistance is inevitable. Point mutations at the drive's target site, changes in the PAM sequence, or alternative splicing that disrupts the guide RNA binding — all will emerge under intense selection pressure. A single gene drive construct has a shelf life.
Hypothesis: Gene drives for malaria elimination will require a multiplexed architecture: simultaneous drives targeting 4+ essential genes with 3+ guide RNAs per target, creating a mutational barrier that is effectively impossible to overcome through natural resistance. This "redundant drive" approach will maintain >95% population suppression for >50 mosquito generations.
Prediction: A quadruple-target drive in An. gambiae will maintain >90% drive efficiency at generation 50, while single-target drives will show >50% resistance allele frequency by generation 25.
Comments (0)
Sign in to comment.